Fresenius Medical Care reported €3.29B in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Akzo Nobel AKZA:NA 1.54B 50M
Alcon AG ALC:SW 972M 29M
AstraZeneca AZN:LN 2279M 790M
Bayer BAYN:GR € 5176M 1491M
Davita Healthcare Partners DVA:US $ 2018.53M 41.69M
E.ON EOAN:GR 36.34B 7.6B
Fresenius FRE:GR € 7162M 92M
Fresenius Medical Care FME:GR € 3290.27M 37.59M
Fresenius Medical Care FMS:US $ 3290.27M 37.59M
Getinge GETIB:SS 3.13B 919M
Givaudan GIVN:VX 1.94B 43M
GlaxoSmithKline GSK:LN 3645M 30M
GN Store Nord GN:DC 2.05B 176M
GRIFOLS GRF:SM € 771.1M 119.7M
Hikma Pharmaceutical HIK:LN 652M 52M
Lonza Group LONN:SW 1.8B 301M
Merck MRK:GR € 1987M 28M
Novartis NOVN:VX SF 3755M 245M
Philips PHIA:NA € 2407M 618M
RWE RWE:GR € 7515M 41M
SAP SAP:GR € 2044M 53M
William Demant Holding WDH:DC 2.28B 14M